Insider Buy/Sell Details for the Biotechnology Industry — Last 7 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (245)
Oruka Therapeutics, Inc. (ORKA)
Goncalves Joana — Chief Medical Officer
Shares
3,150
Price
$92.03
Total Value
$289.89K
Shares Held After
34,184
% of Holdings
8.4%
Oruka Therapeutics, Inc. (ORKA)
Goncalves Joana — Chief Medical Officer
Shares
2,384
Price
$91.10
Total Value
$217.17K
Shares Held After
37,334
% of Holdings
6.0%
Oruka Therapeutics, Inc. (ORKA)
Sandler Laura Lee — Chief Operating Officer
Shares
906
Price
$95.71
Total Value
$86.71K
Shares Held After
235,478
% of Holdings
0.4%
Ultragenyx Pharmaceutical Inc. (RARE)
Huizenga Theodore Alan — SVP, Chief Accounting Officer
Shares
1,283
Price
$13.57
Total Value
$17.41K
Shares Held After
67,863
% of Holdings
1.9%
Inhibrx Biosciences, Inc. (INBX)
MANHARD KIMBERLY — Director
Shares
500
Price
$105.05
Total Value
$52.52K
Shares Held After
7,500
% of Holdings
6.2%
CYTOKINETICS INC (CYTK)
Landry Robert E — Director
Shares
1,000
Price
$72.13
Total Value
$72.13K
Shares Held After
8,184
% of Holdings
10.9%
CYTOKINETICS INC (CYTK)
Blum Robert I — Director
Shares
97,926
Price
$69.33
Total Value
$6.79M
Shares Held After
0
% of Holdings
100.0%
PUMA BIOTECHNOLOGY, INC. (PBYI)
Cesano Alessandra — Director
Shares
62,150
Price
$9.12
Total Value
$566.99K
Shares Held After
56,700
% of Holdings
52.3%
PUMA BIOTECHNOLOGY, INC. (PBYI)
WILSON TROY EDWARD — Director
Shares
5,000
Price
$9.10
Total Value
$45.50K
Shares Held After
54,750
% of Holdings
8.4%
InMed Pharmaceuticals Inc. (INM)
ADAR1 Capital Management, LLC — 10% Owner
Shares
28,505
Price
$1.29
Total Value
$36.88K
Shares Held After
829,505
% of Holdings
3.4%
4D Molecular Therapeutics, Inc. (FDMT)
Kirn David — Director
Shares
58,333
Price
$13.90
Total Value
$811.00K
Shares Held After
767,486
% of Holdings
7.1%
Moderna, Inc. (MRNA)
Hoge Stephen — President
Shares
40,294
Price
$144.13
Total Value
$5.81M
Shares Held After
1,525,858
% of Holdings
2.6%
VERACYTE, INC. (VCYT)
Holstein Jens — Director
Shares
5,000
Price
$40.95
Total Value
$204.75K
Shares Held After
27,471
% of Holdings
15.4%
CORCEPT THERAPEUTICS INC (CORT)
Lyon Joseph Douglas — Chief Accounting&Technology Officer
Shares
2,188
Price
$114.12
Total Value
$249.69K
Shares Held After
5,683
% of Holdings
27.8%
CORCEPT THERAPEUTICS INC (CORT)
Lyon Joseph Douglas — Chief Accounting&Technology Officer
Shares
7,812
Price
$113.32
Total Value
$885.26K
Shares Held After
7,871
% of Holdings
49.8%
YD Bio Ltd (YDES)
Shen Ethan PhD — Director
Shares
12,700
Price
$3.85
Total Value
$48.90K
Shares Held After
11,258,331
% of Holdings
0.1%
FRACTYL HEALTH, INC. (GUTS)
BRADLEY WILLIAM — Director
Shares
64,516
Price
$0.62
Total Value
$39.90K
Shares Held After
149,138
% of Holdings
43.3%
Pharvaris N.V. (PHVS)
Souverijns Wim — Chief Commercial Officer
Shares
20,000
Price
$39.31
Total Value
$786.13K
Shares Held After
45,111
% of Holdings
30.7%
PALVELLA THERAPEUTICS, INC. (PVLA)
JENKINS GEORGE M — Director
Shares
1,560
Price
$153.10
Total Value
$238.83K
Shares Held After
161,893
% of Holdings
1.0%
PALVELLA THERAPEUTICS, INC. (PVLA)
JENKINS GEORGE M — Director
Shares
6,160
Price
$152.12
Total Value
$937.03K
Shares Held After
163,453
% of Holdings
3.6%
PALVELLA THERAPEUTICS, INC. (PVLA)
JENKINS GEORGE M — Director
Shares
5,632
Price
$151.46
Total Value
$853.04K
Shares Held After
169,613
% of Holdings
3.2%
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)
GARNETT KEITHLY — CFO
Shares
257
Price
$3.89
Total Value
$1.00K
Shares Held After
242,357
% of Holdings
0.1%
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)
Heshmatpour Amir F — Director
Shares
15,000
Price
$3.96
Total Value
$59.40K
Shares Held After
3,148,000
% of Holdings
0.5%
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)
CHEN THOMAS C — Director
Shares
5,242
Price
$3.81
Total Value
$20.00K
Shares Held After
24,503
% of Holdings
21.4%
Century Therapeutics, Inc. (IPSC)
Russotti Gregory — Chief Technology and Manufacturing Officer
Shares
2,587
Price
$1.93
Total Value
$4.99K
Shares Held After
509,198
% of Holdings
0.5%
Century Therapeutics, Inc. (IPSC)
Carr Douglas — SVP Finance&Operations
Shares
1,658
Price
$1.93
Total Value
$3.20K
Shares Held After
502,907
% of Holdings
0.3%
Inhibrx Biosciences, Inc. (INBX)
MANHARD KIMBERLY — Director
Shares
500
Price
$110.26
Total Value
$55.13K
Shares Held After
8,000
% of Holdings
5.9%
CYTOKINETICS INC (CYTK)
Blum Robert I — Director
Shares
7,500
Price
$73.44
Total Value
$550.80K
Shares Held After
377,820
% of Holdings
1.9%
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
Ben Yong — Director
Shares
2,000
Price
$7.84
Total Value
$15.68K
Shares Held After
9,383
% of Holdings
17.6%
Mirum Pharmaceuticals, Inc. (MIRM)
BJERKHOLT ERIC — CHIEF FINANCIAL OFFICER
Shares
9,943
Price
$98.37
Total Value
$978.09K
Shares Held After
44,745
% of Holdings
18.2%
Korro Bio, Inc. (KRRO)
FORMELA JEAN FRANCOIS — Director
Shares
6,602
Price
$14.12
Total Value
$93.22K
Shares Held After
132,650
% of Holdings
4.7%
Korro Bio, Inc. (KRRO)
FORMELA JEAN FRANCOIS — Director
Shares
31,888
Price
$14.12
Total Value
$450.26K
Shares Held After
640,610
% of Holdings
4.7%
Liquidia Corp (LQDA)
SINGH RAMAN — Director
Shares
8,468
Price
$66.16
Total Value
$560.24K
Shares Held After
44,637
% of Holdings
15.9%
NewAmsterdam Pharma Co N.V. (NAMS)
Davidson Michael H. — Director
Shares
10,000
Price
$22.65
Total Value
$226.50K
Shares Held After
792,923
% of Holdings
1.3%
UNITED THERAPEUTICS Corp (UTHR)
Mesa Nilda — Director
Shares
98
Price
$505.98
Total Value
$49.59K
Shares Held After
5,580
% of Holdings
1.7%
UNITED THERAPEUTICS Corp (UTHR)
Mesa Nilda — Director
Shares
130
Price
$505.79
Total Value
$65.75K
Shares Held After
6,430
% of Holdings
2.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
440
Price
$506.48
Total Value
$222.85K
Shares Held After
324,443
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,400
Price
$505.25
Total Value
$1.21M
Shares Held After
324,883
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,722
Price
$504.47
Total Value
$1.37M
Shares Held After
327,283
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,358
Price
$503.44
Total Value
$1.19M
Shares Held After
330,005
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,580
Price
$502.15
Total Value
$793.40K
Shares Held After
332,363
% of Holdings
0.5%
AIM ImmunoTech Inc. (AIM)
Equels Thomas K — Director
Shares
5,900
Price
$0.22
Total Value
$1.29K
Shares Held After
69,822
% of Holdings
8.5%
Pharvaris N.V. (PHVS)
Modig Berndt — Director
Shares
2,291
Price
$39.40
Total Value
$90.28K
Shares Held After
128,334
% of Holdings
1.8%
MAIA Biotechnology, Inc. (MAIA)
Vitoc Vlad — Director
Shares
73,000
Price
$1.37
Total Value
$100.01K
Shares Held After
1,049,121
% of Holdings
7.0%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Meeker David P — Director
Shares
2,300
Price
$105.19
Total Value
$241.94K
Shares Held After
239,258
% of Holdings
1.0%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Meeker David P — Director
Shares
1,817
Price
$104.55
Total Value
$189.96K
Shares Held After
241,558
% of Holdings
0.7%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Meeker David P — Director
Shares
8,698
Price
$103.43
Total Value
$899.63K
Shares Held After
243,375
% of Holdings
3.5%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Meeker David P — Director
Shares
30,746
Price
$102.35
Total Value
$3.15M
Shares Held After
252,073
% of Holdings
10.9%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Meeker David P — Director
Shares
6,439
Price
$101.75
Total Value
$655.15K
Shares Held After
282,819
% of Holdings
2.2%
BioNTech SE (BNTX)
Sahin Ugur — Chief Executive Officer
Shares
41,000
Price
$99.45
Total Value
$4.08M
Shares Held After
602,209
% of Holdings
6.4%
Showing 51–100 of 245 transactions (page 2 of 5)